| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tucker Sean | SVP, Chief Scientific Officer | C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO | /s/ Edward Berg, Attorney-in-Fact | 05 Feb 2026 | 0001652204 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VXRT | Common Stock | Tax liability | $5,638 | -9,265 | -1.3% | $0.6085 | 731,225 | 02 Feb 2026 | Direct | F1 |
| holding | VXRT | Common Stock | 51,465 | 02 Feb 2026 | By joint tenancy with Frances Chang and Sean Tucker | ||||||
| holding | VXRT | Common Stock | 9,060 | 02 Feb 2026 | By Spouse |
| Id | Content |
|---|---|
| F1 | Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2026. |